Correlation Between DexCom and XTANT MEDICAL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and XTANT MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and XTANT MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and XTANT MEDICAL HLDGS, you can compare the effects of market volatilities on DexCom and XTANT MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of XTANT MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and XTANT MEDICAL.

Diversification Opportunities for DexCom and XTANT MEDICAL

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between DexCom and XTANT is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and XTANT MEDICAL HLDGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTANT MEDICAL HLDGS and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with XTANT MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTANT MEDICAL HLDGS has no effect on the direction of DexCom i.e., DexCom and XTANT MEDICAL go up and down completely randomly.

Pair Corralation between DexCom and XTANT MEDICAL

Assuming the 90 days horizon DexCom Inc is expected to generate 0.47 times more return on investment than XTANT MEDICAL. However, DexCom Inc is 2.14 times less risky than XTANT MEDICAL. It trades about 0.13 of its potential returns per unit of risk. XTANT MEDICAL HLDGS is currently generating about -0.14 per unit of risk. If you would invest  6,343  in DexCom Inc on September 23, 2024 and sell it today you would earn a total of  1,158  from holding DexCom Inc or generate 18.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  XTANT MEDICAL HLDGS

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, DexCom reported solid returns over the last few months and may actually be approaching a breakup point.
XTANT MEDICAL HLDGS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTANT MEDICAL HLDGS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

DexCom and XTANT MEDICAL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and XTANT MEDICAL

The main advantage of trading using opposite DexCom and XTANT MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, XTANT MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will offset losses from the drop in XTANT MEDICAL's long position.
The idea behind DexCom Inc and XTANT MEDICAL HLDGS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas